Brooks A M, Hussein S, Chesterman C N, Martin J F, Alford F P, Penington D G
Thromb Haemost. 1983 Apr 28;49(2):123-7.
Twenty control subjects, 12 insulin treated and 10 non-insulin treated diabetics were studied. All diabetics had retinopathy documented by fluorescein angiography and fluorophotometry. Factor VIIIR:Ag and plasma fibrinogen concentrations were elevated in both diabetic groups, but more so in the insulin treated patients. Within this latter group the plasma fibrinogen was also correlated with the degree of retinopathy. Platelets separated on linear isosmolar Percoll gradients showed an increase in intraplatelet beta TG content and concentration and a slight increase in volume of the lightest platelets in the insulin treated diabetics. Plasma platelet factor 4 and antithrombin III concentrations were normal and plasma beta TG levels were elevated only in those patients with renal insufficiency. Platelet aggregometry was performed in 18 diabetic subjects and found to be normal. It is concluded that abnormalities of coagulation and platelets in diabetes are determined by metabolic factors rather than the severity of microvascular disease per se.
对20名对照受试者、12名接受胰岛素治疗的糖尿病患者和10名未接受胰岛素治疗的糖尿病患者进行了研究。所有糖尿病患者均通过荧光素血管造影和荧光光度法记录有视网膜病变。两个糖尿病组的因子VIIIR:Ag和血浆纤维蛋白原浓度均升高,但在接受胰岛素治疗的患者中升高更为明显。在后者这组中,血浆纤维蛋白原也与视网膜病变程度相关。在等渗线性Percoll梯度上分离的血小板显示,接受胰岛素治疗的糖尿病患者血小板内β-血小板球蛋白含量和浓度增加,最轻的血小板体积略有增加。血浆血小板因子4和抗凝血酶III浓度正常,仅在那些肾功能不全的患者中血浆β-血小板球蛋白水平升高。对18名糖尿病受试者进行了血小板聚集测定,结果发现正常。得出的结论是,糖尿病患者凝血和血小板异常是由代谢因素决定的,而非微血管疾病本身的严重程度。